Cargando…

Insulin Receptor Isoform Variations in Prostate Cancer Cells

Men who develop prostate cancer (PCa) increasingly have one of the co-morbidities associated with a Western lifestyle that are characterized by hyperinsulinemia, hyperglycemia and increased expression of insulin-like growth factors-I (IGF-I) and IGF-II. Each have been associated with poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perks, Claire M., Zielinska, H. A., Wang, Jing, Jarrett, Caroline, Frankow, A., Ladomery, Michael R., Bahl, Amit, Rhodes, Anthony, Oxley, Jon, Holly, Jeff M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039983/ https://www.ncbi.nlm.nih.gov/pubmed/27733843 http://dx.doi.org/10.3389/fendo.2016.00132

Ejemplares similares

Hyperglycemia Promotes TMPRSS2-ERG Gene Fusion in Prostate Cancer Cells via Upregulating Insulin-Like Growth Factor-Binding Protein-2
por: Holly, Jeff M. P., et al.
Publicado: (2017)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska, Hanna A, et al.
Publicado: (2015)

Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide
por: Perks, Claire M., et al.
Publicado: (2011)

Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
por: Zeng, Li, et al.
Publicado: (2014)

Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential
por: Holly, Jeff M. P., et al.
Publicado: (2019)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
por: Holly, Jeff M. P., et al.
Publicado: (2020)

Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer
por: Hackshaw-McGeagh, Lucy E, et al.
Publicado: (2019)

Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs
por: Jiráček, Jiří, et al.
Publicado: (2017)

Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?
por: Barker, Rachel M., et al.
Publicado: (2020)

IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
por: Mansor, Rehanna, et al.
Publicado: (2020)

Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
por: Mansor, Rehanna, et al.
Publicado: (2023)

Interaction between GRP78 and IGFBP-3 Affects Tumourigenesis and Prognosis in Breast Cancer Patients
por: Zielinska, Hanna A., et al.
Publicado: (2020)

Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial
por: Hackshaw-McGeagh, Lucy, et al.
Publicado: (2016)

Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism
por: Zielinska, H.A., et al.
Publicado: (2018)

Grand Challenges in Cancer Endocrinology: Endocrine Related Cancers, an Expanding Concept
por: Belfiore, Antonino, et al.
Publicado: (2013)

Editorial: insights in cancer endocrinology 2021
por: Perks, Claire M., et al.
Publicado: (2022)

Editorial: Insights in cancer endocrinology: 2022
por: Perks, Claire M., et al.
Publicado: (2023)

The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer
por: Holly, Jeff M. P., et al.
Publicado: (2019)

Editorial: Special 2021 Frontiers in Endocrinology collection for the 100(th) anniversary of insulin discovery
por: De Meyts, Pierre, et al.
Publicado: (2023)

Editorial: Cell Signaling in Tumors of Endocrine and Endocrine-Responsive Tissues
por: Perks, Claire, et al.
Publicado: (2019)

Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
por: Kingshott, Georgina, et al.
Publicado: (2021)

Editorial: Women in endocrinology 2021
por: Perks, Claire M., et al.
Publicado: (2022)

A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?
por: Mashat, Reham M., et al.
Publicado: (2021)

Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2
por: Al Qahtani, Athba, et al.
Publicado: (2017)

Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer
por: McGeagh, Lucy, et al.
Publicado: (2022)

Current Understanding of Circulating Tumor Cells – Potential Value in Malignancies of the Central Nervous System
por: Adamczyk, Lukasz A., et al.
Publicado: (2015)

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel
por: Uzoh, C C, et al.
Publicado: (2011)

Growth Hormone and Insulin-like Growth Factor-I Molecular Weight Isoform Responses to Resistance Exercise Are Sex-Dependent
por: Pierce, Joseph R., et al.
Publicado: (2020)

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)

Individual Response Variation in the Effects of Weight Loss and Exercise on Insulin Sensitivity and Cardiometabolic Risk in Older Adults
por: Brennan, Andrea M., et al.
Publicado: (2020)

Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome
por: Vestey, Sarah B, et al.
Publicado: (2005)

Ligand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes
por: Rajapaksha, Harinda, et al.
Publicado: (2015)

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2
por: Sarkar, Phoebe L., et al.
Publicado: (2019)

Challenges in Endocrinology: Moving from the Post-Genomic Era, into the Nano-World and Beyond
por: Holly, Jeff M. P.
Publicado: (2011)

Commentary: A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. A Metabolic Endocrinology Perspective
por: Holly, Jeff M. P.
Publicado: (2022)

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines
por: Koobotse, Moses, et al.
Publicado: (2018)

Advances in Cellular Characterization of the Sirtuin Isoform, SIRT7
por: Wu, Di, et al.
Publicado: (2018)

Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis
por: Wei, Lei, et al.
Publicado: (2022)

HNF4α isoforms: the fraternal twin master regulators of liver function
por: Radi, Sarah H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nctrnuul72b4inds87g6t92sne